查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1834095

低溫管瓶市場：按材料、容量、無菌性、封閉性、自動化相容性、最終用戶和應用分類 - 全球預測 2025-2032

Cryogenic Vials Market by Material, Volume, Sterility, Closure, Automation Compatibility, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，低溫管瓶市場將成長至 8.4298 億美元，複合年成長率為 5.42%。

主要市場統計數據
基準年2024年 5.5233億美元
預計2025年 5.8267億美元
預測年份：2032年 8.4298億美元
複合年成長率（%） 5.42%

簡明解釋為什麼您選擇的低溫管瓶會影響實驗室完整性、自動化相容性以及生命科學工作流程中的下游樣品價值

低溫管瓶的應用範圍涵蓋生物醫學研究、診斷、生物樣本庫和治療開發等關鍵工作流程。材料科學、封閉技術和自動化相容性的最新創新，正在將管瓶從一個簡單的容器提升為實驗室品質系統的重要組成部分。隨著樣本完整性標準日益嚴格，通量需求不斷成長，實驗室和生物樣本庫正在重新調整其供應商選擇標準，優先考慮無菌保證、可追溯性以及與自動化平台的生命週期相容性。

本介紹解釋了為什麼低溫管瓶的選擇不僅僅關乎儲存。材料性能、密封可靠性和自動化相容性的相互作用決定了樣品的長期存活率和操作效率。從學術實驗室到藥物研發團隊，相關人員需要能夠無縫整合到其工作流程中的管瓶，同時滿足無菌和污染控制方面的監管要求。因此，採購決策現在不僅取決於價格，還取決於對產品屬性、供應商能力以及對下游營運影響的多方面評估。

展望未來，市場參與企業應該期望他們的採購和研發團隊要求標準化規範，以減少整個供應鏈的變化並支援與自動化系統的互通性。本介紹為深入探討產業轉型、關稅導致的供應鏈壓力、細分細微差別、區域差異、競爭動態以及為尋求駕馭快速發展的生態系統的領導者提供實用建議奠定了基礎。

材料、封閉工程和自動化相容性的進步如何融合，重新定義產品標準、供應商檢驗和採購期望

低溫管瓶產業正在經歷一場變革，其驅動力來自技術、監管和營運因素，這些因素正在重新定義產品要求和供應商期望。聚合物化學和玻璃配方的進步使其具有耐低溫性能，並減少了可萃取物，從而增強了樣品的長期儲存能力，並使其更適用於敏感的檢測。同時，從增強型O形圈材料到磁性和卡扣式瓶蓋設計的瓶蓋創新，正在降低洩漏風險，並促進日常物料輸送中快速、可靠的取用。

同時，自動化浪潮正在改變採購重點。全自動和半自動化系統需要標準化的管瓶形狀、堅固的封蓋介面和一致的製造公差，以確保可靠的取放操作。這種轉變強調了供應商能夠檢驗相容性並提供機器人操作的測試數據。法規和品質要求也日益嚴格，要求供應商在標準商業性合約中提供滅菌驗證、可追溯性記錄和材料安全文件。

最後，供應鏈彈性和環境考量正在推動製造商最佳化物流，並探索可回收和低碳材料的選擇。這些因素的匯聚正迫使現有企業和新參與企業都在產品差異化、認證途徑以及與最終用戶的共同檢驗方面進行投資，以在日益嚴峻的市場中保持競爭力。

了解美國關稅措施的變化將如何影響低溫管瓶相關人員的供應鏈策略、採購決策和業務連續性

源自美國的關稅政策發展和貿易行動可能會對管瓶供應鏈中的零件採購、製造足跡和定價策略產生重大影響。當進口關稅和相關貿易法規調整時，下游採購商通常面臨更長的採購前置作業時間和更高的國際採購產品和原料到岸成本。此類成本壓力往往促使製造商重新評估籌資策略，例如近岸外包、回岸外包或多元化供應商基礎，以降低風險並穩定供應連續性。

政策週期內關稅變動的累積效應通常會波及到製造決策和庫存策略。供應商可能會加速垂直整合，將關鍵流程外包，並減輕關稅波動的影響，或者他們可能會重新協商合約條款，將成本轉嫁給最終買家。在營運方面，由於供應商優先考慮在新的貿易條件下更具經濟可行性的核心SKU，實驗室和生物樣本庫的管理人員可能會面臨間歇性的SKU合理化。同時，如果原料集中在受關稅影響的地區，依賴特殊玻璃配方或特定聚合物等級的組織可能會面臨採購摩擦。

為了因應這些動態，商業領袖應將關稅情境規劃納入其採購和定價框架，儘早評估替代材料和供應商方案，並與值得信賴的供應商進行聯合預測。即使貿易政策變化導致市場暫時中斷，就成本結構和應急計畫進行透明的對話也將有助於穩定供應鏈、維護產品品質並維持服務水準。

深度細分分析揭示了材料化學、體積格式、封閉機制和自動化相容性如何影響產品設計和採購選擇

細分市場動態揭示了低溫凍存管瓶領域產品設計和最終用戶需求的差異。硼矽酸和鈉石灰等玻璃具有不同的熱穩定性和化學穩定性，而聚乙烯和聚丙烯等塑膠則具有更高的抗衝擊性和可客製化的成型工藝，從而易於實現自動化生產。因此，材料決策——平衡熱性能、與低溫保存介質的兼容性以及物料輸送的耐用性——會影響不同類型實驗室的採購選擇。

1.5毫升、2毫升、5毫升和10毫升等容量類別直接考慮了樣本類型和通量。較小的容量支援微量滴定工作流程和高密度生物樣本庫，而較大的容量則適用於大量儲存和運輸。無菌產品分為非無菌產品和無菌產品，它們決定了市場對無菌驗證和包裝控制的期望，尤其是涉及臨床或監管研究樣本時。密封系統——磁力蓋、O形圈、螺旋蓋、卡扣蓋——是容器完整性和快速取用之間的關鍵介面，每種密封類型都在防洩漏性、自動化兼容性和用戶人體工學之間進行了權衡。

自動化適用性將產品分為全自動、半自動和手動類別，規定了設計公差、插入/移除可靠性以及條碼和機架介面要求。涵蓋學術和研究機構、生物庫、生物技術公司、診斷實驗室、醫院和製藥公司的最終用戶細分闡明了預期性能如何根據應用環境、監管負擔和吞吐量需求而變化。最後，專注於冷凍保存、樣品儲存和運輸等應用的細分融合了功能要求。例如，運輸管瓶優先考慮抗衝擊性和安全封閉性，而冷凍保存管瓶強調熱循環耐久性和最小可萃取物。這些細分層共同構成一個矩陣，為尋求滿足客戶需求的供應商提供產品藍圖、驗證承諾和商業性定位的資訊。

美洲、歐洲、中東和非洲地區以及亞太地區的需求模式、管理體制和供應鏈基礎設施將如何影響產品預期和打入市場策略

區域動態塑造了美洲、歐洲、中東和非洲以及亞太地區的需求促進因素、監管預期和供應商生態系統，從而對低溫管瓶相關人員產生了獨特的營運和商業影響。美洲地區擁有大量研究實驗室、生物製藥開發和成熟的生物銀行樣本庫，推動了對檢驗和記錄的產品的需求以及高水準的服務期望。該地區高度重視供應商的回應能力、快速的前置作業時間以及適用於臨床研發開發平臺的無菌認證產品線的可用性。

在歐洲、中東和非洲，監管協調工作和密集的臨床實驗室網路指南產品合規性和可追溯性實踐。在該地區營運的供應商必須遵循錯綜複雜的國家法規，同時滿足嚴格的品質系統要求，並且通常必須支援多語言文件和區域分銷策略。在亞太地區，不斷增加的研究投資、不斷擴大的叢集以及不斷提升的診斷能力，正在推動對經濟高效的塑膠解決方案和高性能玻璃器皿的廣泛需求。瞄準該地區的製造商通常強調擴充性的生產、本地夥伴關係和客製化，以支援多樣化的最終用戶群。

綜合起來，這些區域模式表明，供應商可以從量身定做的市場進入方法中受益，該方法將全球產品標準與特定區域的支援、監管專業知識以及解決當地基礎設施和採購行為的物流解決方案相結合。

競爭壓力凸顯了身為市場領導者，經過檢驗的自動化相容性、透明的品質系統和供應鏈彈性的重要性

低溫管瓶領域的競爭態勢取決於產品創新、生產規模以及檢驗與實驗室自動化和法規要求相容性的能力。領先的供應商透過對先進材料、密封系統和滅菌驗證的投資來脫穎而出，而其他供應商則在成本和針對大型機構客戶的客製化能力方面展開競爭。管瓶製造商與自動化供應商或實驗室整合商之間的策略夥伴關係，可以降低整合風險並加速其在高通量環境中的應用，從而強化價值命題。

供應方的競爭力也取決於品管體係以及透明的材料和製程文件。提供強大的可追溯性、批次級測試和第三方認證的公司通常能夠確保其作為臨床和製藥終端用戶的首選供應商的地位。製造地和供應鏈的韌性構成了另一個競爭力核心。擁有多元化生產基地和強大區域分銷網路的公司更有能力應對關稅衝擊和物流中斷。

最後，專注於永續性認證、可回收材料和新型封蓋技術的新參與企業正在重塑買家的期望。現有供應商可能會透過擴展產品線和策略性併購來應對，從而縮短經過驗證的自動化產品的上市時間。整體而言，競爭不僅需要強大的產品，還需要可驗證的品質系統、驗證支援以及與客戶工作流程一致的營運可靠性。

製造商和採購商採取切實可行的策略行動，加強驗證能力、多樣化投入、增強可追溯性，以保護樣品的完整性和供應的連續性。

產業領導者應採取可行的策略，使產品開發與不斷發展的實驗室工作流程、監管要求和供應鏈現實一致。首先，投資於跨職能驗證項目，這些項目應在領先的自動化平台上展示可靠的效能，並為客戶提供清晰、可重複的驗收標準。此類驗證可以降低整合風險，縮短引進週期，並在向高通量實驗室和生物樣本庫銷售產品時創造穩固的商業性優勢。

其次，它增強了材料和瓶蓋的多樣化，並降低了特定投入品供應中斷的風險。對替代玻璃配方和聚合物等級進行認證，並檢驗關鍵SKU的多種瓶蓋類型，使製造商能夠更靈活地應對關稅變化、原料短缺和需求激增。第三，它透過提供無菌證書、可萃取物/可浸出物資料和批次級可追溯性，增強了文件記錄和可追溯性服務，滿足了臨床和製藥客戶的文件記錄需求。清晰的文件記錄有助於採購評估，並縮短受監管買家的資格確認時間。

第四，我們優先考慮區域製造和經銷夥伴關係，以縮短前置作業時間並降低運費敏感度。最後，我們透過協作測試、客製化檢驗計劃和教育計畫積極與最終用戶互動，以確保我們的產品設計能夠應對實際操作中的挑戰，並在整個生命週期中保持樣品的完整性。

一種透明的、三管齊下的研究途徑，結合主要相關人員訪談、技術文獻綜合和產品檢驗審查，得出可行的建議

本研究採用結構化方法，結合主要相關人員訪談、產品規格審查以及對監管指南和技術文獻的案頭綜合，建構了堅實的分析基礎。主要輸入包括與實驗室經理、採購主管、品質保證專業人員和產品工程師的對話，以了解疼痛管理的營運實務、驗證要求和供應商選擇標準。這些定性見解與製造商的技術文件、滅菌方案和材料科學出版物進行了交叉引用，以確認產品聲稱的性能與實驗室實際需求之間的一致性。

二次分析納入了官方監管指南、標準文件以及專家同行評審的關於低溫保存、超低溫材料穩定性和封蓋性能的研究。在適當情況下，對設計屬性進行了比較評估，以評估與材料相關的風險，包括自動化相容性、封蓋完整性和可萃取物。調查方法強調來源歸屬的透明度、對專有聲明的謹慎處理，以及基於情境的供應鏈和政策影響分析，以指導實際建議。

調查方法的限制包括供應商文件方法的多樣性以及不斷發展的自動化標準，這些都可能影響研究的普遍性。為了克服這些局限性，該方法優先考慮跨多個獨立資訊來源的交叉檢驗，並盡可能納入最終用戶的測試回饋，以確保研究結果與實際操作相符。

總結為什麼材料性能、檢驗的自動化相容性和彈性採購對於保護樣品完整性和操作連續性至關重要

總而言之，低溫管瓶領域正在從一種商品化的容器轉變為性能關鍵型組件，影響樣本的完整性、實驗室通量和監管環境。材料創新和封蓋工程正在滿足更嚴格的低溫保存和高靈敏度檢測的需求，而自動化相容性正逐漸成為一項關鍵的商業性差異化因素，它能夠減少物料輸送的差異性並加速實驗室工作流程。這些技術趨勢與地緣政治和關稅驅動的供應鏈動態同步發展，因此需要製定積極主動的籌資策略和應急計畫。

對於研究、診斷、生物樣本庫和製藥公司的相關人員來說，優先檢驗自動化相容性，堅持全面的文件記錄和可追溯性，並聘請具備營運韌性和本地支援能力的供應商，才是未來的發展方向。投資於材料多樣化、經驗證的封蓋和協作驗證專案的製造商，將更有能力滿足現代實驗室日益嚴格的品質和吞吐量要求。

總的來說，這些發展凸顯了需要採取一種策略性的、基於證據的方法來選擇管瓶和設計供應鏈，以保留樣品價值、最大限度地降低操作風險、並使產品功能適應不斷發展的實驗室工作流程。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 針對機器人處理進行最佳化的自動化相容低溫管瓶快速增加
  • 推出可減少塑膠廢棄物的環保低溫管瓶材料
  • 支援數位 RFID 的低溫管瓶在低溫運輸追蹤中的應用日益廣泛
  • 對高通量板式低溫儲存系統的需求推動了管瓶的創新
  • 開發先進的密封技術以防止樣品污染
  • 加強實驗室標準化低溫管瓶檢驗通訊協定的監管
  • 用於保存光敏生物分子的抗紫外線低溫管瓶的需求日益成長

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章 低溫管瓶市場（依材料）

  • 玻璃
    • 硼矽酸
    • 鈉石灰
  • 塑膠
    • 聚乙烯
    • 聚丙烯

9. 低溫管瓶市場（按數量）

  • 1.5ml
  • 10ml
  • 2ml
  • 5ml

第 10 章低溫管瓶市場：無菌性

  • 非無菌
  • 已滅菌

第 11 章 低溫管瓶市場（依封閉）

  • 磁扣
  • O形圈
  • 螺旋蓋
  • 按扣帽

第 12 章低溫管瓶市場：自動化適用性

  • 全自動
  • 手動的
  • 半自動

第 13 章。低溫管瓶市場（按最終用戶）

  • 學術研究機構
  • 生物樣本庫
  • 生技公司
  • 診斷實驗室
  • 醫院
  • 製藥公司

第14章 低溫管瓶市場（依應用）

  • 冷凍保存
  • 樣品儲存
  • 運輸

第 15 章。按地區分類的低溫管瓶市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 低溫管瓶市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 低溫管瓶市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Corning Incorporated
    • Avantor, Inc.
    • Greiner Bio-One International GmbH
    • DWK Life Sciences GmbH
    • Eppendorf AG
    • Cole-Parmer Instrument Company, LLC
    • Labcon, Inc.
    • Simport Scientific Inc.
Product Code: MRR-4311CE1A33F4

The Cryogenic Vials Market is projected to grow by USD 842.98 million at a CAGR of 5.42% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 552.33 million
Estimated Year [2025] USD 582.67 million
Forecast Year [2032] USD 842.98 million
CAGR (%) 5.42%

A concise framing of why cryogenic vial selection now drives laboratory integrity, automation compatibility, and downstream sample value across life sciences workflows

The cryogenic vial landscape underpins critical workflows across biomedical research, diagnostics, biobanking, and therapeutic development. Recent innovations in material science, closure technologies, and automation compatibility have elevated the role of vials from mere containers to integral components of laboratory quality systems. As sample integrity standards tighten and throughput demands increase, laboratories and biorepositories are recalibrating vendor selection criteria to prioritize sterility assurance, traceability, and lifecycle compatibility with automated platforms.

This introduction frames why cryogenic vial selection matters beyond simple storage. The interplay of material performance, closure reliability, and automation-readiness governs long-term sample viability and operational efficiency. Stakeholders from academic research labs to pharmaceutical development teams require vials that integrate seamlessly into workflows while meeting regulatory expectations for sterility and contamination control. Consequently, procurement decisions now hinge on a multidimensional assessment of product attributes, supplier capabilities, and downstream operational impacts rather than price alone.

Looking forward, market participants should expect procurement and R&D teams to demand standardized specifications that reduce variability across supply chains and support interoperability with automated systems. This introduction sets the stage for a deeper exploration of transformative industry shifts, tariff-driven supply chain pressures, segmentation nuances, regional differences, competitive dynamics, and practical recommendations for leaders seeking to navigate a rapidly evolving ecosystem.

How advances in materials, closure engineering, and automation compatibility are converging to redefine product standards, supplier validation, and procurement expectations

The cryogenic vial sector is experiencing transformative shifts driven by technological, regulatory, and operational vectors that collectively redefine product requirements and supplier expectations. Advances in polymer chemistry and glass formulations are delivering improved low-temperature resilience and reduced leachables, enabling longer-term sample preservation and greater compatibility with high-sensitivity assays. At the same time, closure innovations-ranging from enhanced O-ring materials to magnetic and snap cap designs-are addressing leakage risk and facilitating rapid, reliable access during routine handling.

Concurrently, the automation wave is reshaping procurement priorities: fully automated and semi-automated systems demand standardized vial geometries, robust closure interfaces, and consistent manufacturing tolerances to ensure pick-and-place reliability. This shift places a premium on vendors that can validate compatibility and provide test data for robotic handling. Regulatory and quality expectations are also tightening; suppliers are being asked to present sterilization validation, traceability records, and material safety documentation as part of standard commercial engagement.

Finally, supply chain resilience and environmental considerations are pushing manufacturers to optimize logistics and explore recyclable or lower-carbon material choices. These converging forces are compelling incumbents and new entrants alike to invest in product differentiation, certification pathways, and collaborative validation with end users to remain competitive in an increasingly exacting market.

Understanding how shifts in United States tariff measures influence supply chain strategy, sourcing decisions, and operational continuity for cryogenic vial stakeholders

Tariff policy developments and trade measures emanating from the United States can exert outsized influence on component sourcing, manufacturing footprints, and pricing strategies within the cryogenic vial supply chain. When import duties or related trade restrictions are adjusted, downstream purchasers frequently encounter longer procurement lead times and higher landed costs for products or raw inputs sourced internationally. These cost pressures often encourage manufacturers to reassess sourcing strategies, which can include nearshoring, reshoring, or diversifying supplier bases to mitigate risk and stabilize supply continuity.

The cumulative effect of tariff changes in a given policy cycle typically reverberates through manufacturing decisions and inventory strategies. Suppliers may accelerate vertical integration to internalize critical processes and reduce exposure to duty fluctuations, or they may renegotiate contractual terms related to cost-pass-through to end buyers. Operationally, laboratory and biobank managers may face intermittent SKU rationalization as vendors prioritize core SKUs that are more economically viable under new trade conditions. In parallel, organizations that rely on specialized glass formulations or specific polymer grades could face procurement friction if those feedstocks are concentrated in jurisdictions affected by tariffs.

To navigate these dynamics, commercial leaders should incorporate tariff scenario planning into sourcing and pricing frameworks, evaluate alternate material or supplier options early, and engage in collaborative forecasting with trusted suppliers. Transparent dialogue about cost composition and contingency plans will help stabilize supply chains, preserve product quality, and maintain service levels even when trade policy shifts create transient market dislocations.

Deep segmentation analysis revealing how material chemistry, volume formats, closure mechanisms, and automation compatibility sculpt product design and procurement choices

Segment-level dynamics illuminate how product design and end-user requirements diverge across the cryogenic vial landscape. Material selection distinguishes glass and plastic pathways, where glass variants such as borosilicate and soda lime offer differing thermal and chemical stability profiles, and plastic options including polyethylene and polypropylene provide enhanced impact resistance and customizable molding for automation-friendly geometries. Decisions about material thus balance thermal performance, compatibility with cryopreservation media, and handling durability, influencing procurement choices across laboratory types.

Volume segmentation, spanning formats like 1.5ml, 2ml, 5ml, and 10ml, maps directly to sample type and throughput considerations; smaller volumes support microtiter workflows and high-density biobanking while larger formats address bulk storage and transport use cases. Sterility classification into non-sterile and sterile offerings shapes market expectations for sterilization validation and packaging controls, particularly where clinical or regulated research samples are involved. Closure systems-magnetic closure, O-ring, screw cap, and snap cap-represent a critical interface with containment integrity and rapid access, with each closure type offering trade-offs between leak resistance, automation compatibility, and user ergonomics.

Automation compatibility divides products into fully automated, semi-automated, and manual categories and drives design tolerances, insertion/retrieval reliability, and barcode or rack-interface requirements. End-user segmentation covering academic and research institutes, biobanks, biotechnology firms, diagnostic laboratories, hospitals, and pharmaceutical companies underscores how performance expectations vary by application context, regulatory burden, and throughput needs. Finally, application-focused distinctions such as cryopreservation, sample storage, and transport concentrate functional demands; for example, transport vials prioritize shock resistance and secure closures, whereas cryopreservation vials emphasize thermal cycling durability and minimal extractables. Together, these segmentation layers form a matrix that informs product roadmaps, validation commitments, and commercial positioning for suppliers seeking to align with customer requirements.

How regional demand patterns, regulatory regimes, and supply chain infrastructures across the Americas, EMEA, and Asia-Pacific determine product expectations and go-to-market strategies

Regional dynamics shape demand drivers, regulatory expectations, and supplier ecosystems across the Americas, Europe, Middle East & Africa, and Asia-Pacific, producing distinctive operational and commercial implications for cryogenic vial stakeholders. In the Americas, a concentration of research institutions, biopharmaceutical development, and established biobanking activity fuels demand for validated, heavily documented products and high service-level expectations. This region places a premium on supplier responsiveness, rapid lead times, and the availability of sterile, certified product lines suitable for clinical R&D pipelines.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and a dense network of clinical laboratories guide product compliance and traceability practices. Suppliers active in this region must navigate a mosaic of national regulations while meeting stringent quality system requirements, often supporting multilingual documentation and regional distribution strategies. In the Asia-Pacific region, rising research investment, expanding biotech clusters, and growing diagnostic capacity drive broad-based demand for both cost-effective plastic solutions and high-performance glass offerings. Manufacturers targeting this region frequently emphasize scalable production, local partnerships, and customization to support diverse end-user profiles.

Collectively, these regional patterns suggest that suppliers will benefit from tailored go-to-market approaches that combine global product standards with localized support, regulatory expertise, and logistics solutions that address regional infrastructure and procurement behaviors.

Competitive landscape pressures highlight the importance of validated automation compatibility, transparent quality systems, and supply chain resilience for market leadership

Competitive dynamics within the cryogenic vial sector are defined by product innovation, manufacturing scale, and the ability to validate compatibility with laboratory automation and regulatory requirements. Leading suppliers differentiate through investments in advanced materials, closure systems, and sterilization validation, while others compete on cost and customization capacity for large institutional clients. Strategic partnerships between vial manufacturers and automation vendors or laboratory integrators enhance the value proposition by reducing integration risk and accelerating adoption in high-throughput environments.

Supply-side competitiveness also rests on quality management systems and the transparency of material and process documentation. Firms that offer robust traceability, lot-level testing, and third-party certifications typically secure preferred supplier status among clinical and pharmaceutical end users. Manufacturing footprint and supply chain resilience constitute another axis of competitiveness; companies with diversified production locations or strong regional distribution networks are better positioned to absorb tariff shocks and logistics disruptions.

Finally, emerging entrants focusing on sustainability credentials, recyclable materials, or novel closure technologies are reshaping buyer expectations. Incumbent vendors may respond through incremental product enhancements or strategic M&A to expand portfolios and accelerate time-to-market for validated, automation-ready offerings. Overall, competitive success increasingly requires not just a strong product, but demonstrable quality systems, validation support, and operational reliability aligned with customer workflows.

Practical strategic actions for manufacturers and purchasers to strengthen validation capability, diversify inputs, and enhance traceability to safeguard sample integrity and supply continuity

Industry leaders should pursue actionable strategies that align product development with evolving laboratory workflows, regulatory expectations, and supply chain realities. First, invest in cross-functional validation programs that demonstrate reliable performance with leading automation platforms and provide customers with clear, reproducible acceptance criteria. Such validation reduces integration risk, shortens adoption cycles, and creates a defensible commercial advantage when selling into high-throughput laboratories and biobanks.

Second, strengthen material and closure diversification to mitigate exposure to input-specific supply disruptions. By qualifying alternate glass formulations and polymer grades, and by validating multiple closure types for key SKUs, manufacturers can respond more nimbly to tariff shifts, raw material scarcity, or sudden demand spikes. Third, enhance documentation and traceability offerings by providing sterilization certificates, extractables/leachables data, and lot-level traceability to meet the documentation needs of clinical and pharmaceutical customers. Clear documentation supports procurement evaluation and reduces time-to-qualification for regulated buyers.

Fourth, prioritize regional manufacturing and distribution partnerships to shorten lead times and lower freight sensitivity, while exploring sustainable material choices and packaging optimizations to respond to customer ESG goals. Finally, engage proactively with end users through collaborative pilots, custom validation projects, and educational programming to ensure product designs address real-world handling challenges and preserve sample integrity throughout the sample lifecycle.

A transparent and triangulated research approach combining primary stakeholder interviews, technical literature synthesis, and product validation reviews to ground practical recommendations

This research relied on a structured methodology combining primary stakeholder interviews, product specification reviews, and desk-based synthesis of regulatory guidance and technical literature to construct a robust analytical foundation. Primary inputs included dialogues with laboratory managers, procurement leads, quality assurance professionals, and product engineers to capture operational pain points, validation requirements, and vendor selection criteria. These qualitative insights were triangulated with technical documentation from manufacturers, sterilization protocols, and materials science publications to ensure alignment between claimed product performance and practical laboratory needs.

Secondary analysis incorporated public regulatory guidance, standards documents, and peer-reviewed research on cryopreservation, material stability at ultra-low temperatures, and closure performance. Where appropriate, comparative evaluation of design attributes was performed to assess automation compatibility, closure integrity, and material-related risks such as extractables. The methodological approach emphasized transparency in source attribution, careful treatment of proprietary claims, and scenario-based analysis for supply chain and policy impacts to guide practical recommendations.

Limitations of the methodology include variability in vendor documentation practices and the evolving nature of automation standards, which can affect generalizability. To mitigate these limitations, the approach prioritized cross-validation across multiple independent sources and incorporated end-user testing feedback where available to ground findings in operational reality.

Synthesis of why material performance, validated automation compatibility, and resilient sourcing are essential to protect sample integrity and operational continuity

In conclusion, the cryogenic vial landscape is transitioning from commoditized containers to performance-critical components that influence sample integrity, laboratory throughput, and regulatory compliance. Material innovations and closure engineering are meeting the demands of more rigorous cryopreservation and high-sensitivity assays, while automation compatibility is emerging as a key commercial differentiator that reduces handling variability and accelerates laboratory workflows. These technological trends are occurring alongside geopolitical and tariff-driven supply chain dynamics that require proactive sourcing strategies and contingency planning.

For stakeholders across research institutions, diagnostics, biobanking, and pharmaceutical organizations, the path forward includes prioritizing validated compatibility with automation, insisting on comprehensive documentation and traceability, and engaging suppliers that demonstrate operational resilience and regional support capabilities. Manufacturers that invest in material diversification, validated closures, and collaborative validation programs will be better positioned to meet the tightening quality and throughput expectations of modern laboratories.

Taken together, these developments underscore the need for a strategic, evidence-based approach to vial selection and supply chain design that preserves sample value, minimizes operational risk, and aligns product capabilities with evolving laboratory workflows.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Surge in automation-compatible cryogenic vials optimized for robotic handling
  • 5.2. Emergence of eco-friendly cryogenic vial materials reducing plastic waste
  • 5.3. Growing adoption of digital RFID-enabled cryogenic vials for cold chain tracking
  • 5.4. Demand for high-throughput plate-based cryogenic storage systems boosting vial innovation
  • 5.5. Development of advanced hermetic sealing technologies to prevent sample contamination
  • 5.6. Increased regulatory focus on standardized cryogenic vial validation protocols across labs
  • 5.7. Rising need for UV-resistant cryogenic vials in light-sensitive biomolecule preservation

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cryogenic Vials Market, by Material

  • 8.1. Glass
    • 8.1.1. Borosilicate
    • 8.1.2. Soda Lime
  • 8.2. Plastic
    • 8.2.1. Polyethylene
    • 8.2.2. Polypropylene

9. Cryogenic Vials Market, by Volume

  • 9.1. 1.5ml
  • 9.2. 10ml
  • 9.3. 2ml
  • 9.4. 5ml

10. Cryogenic Vials Market, by Sterility

  • 10.1. Non Sterile
  • 10.2. Sterile

11. Cryogenic Vials Market, by Closure

  • 11.1. Magnetic Closure
  • 11.2. O Ring
  • 11.3. Screw Cap
  • 11.4. Snap Cap

12. Cryogenic Vials Market, by Automation Compatibility

  • 12.1. Fully Automated
  • 12.2. Manual
  • 12.3. Semi Automated

13. Cryogenic Vials Market, by End User

  • 13.1. Academic & Research Institutes
  • 13.2. Biobanks
  • 13.3. Biotechnology Firms
  • 13.4. Diagnostic Laboratories
  • 13.5. Hospitals
  • 13.6. Pharmaceutical Companies

14. Cryogenic Vials Market, by Application

  • 14.1. Cryopreservation
  • 14.2. Sample Storage
  • 14.3. Transport

15. Cryogenic Vials Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Cryogenic Vials Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Cryogenic Vials Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Thermo Fisher Scientific Inc.
    • 18.3.2. Merck KGaA
    • 18.3.3. Corning Incorporated
    • 18.3.4. Avantor, Inc.
    • 18.3.5. Greiner Bio-One International GmbH
    • 18.3.6. DWK Life Sciences GmbH
    • 18.3.7. Eppendorf AG
    • 18.3.8. Cole-Parmer Instrument Company, LLC
    • 18.3.9. Labcon, Inc.
    • 18.3.10. Simport Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CRYOGENIC VIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. CRYOGENIC VIALS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. CRYOGENIC VIALS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CRYOGENIC VIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CRYOGENIC VIALS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CRYOGENIC VIALS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 316. AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 317. AFRICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 318. AFRICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 319. AFRICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 320. AFRICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 321. AFRICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 322. AFRICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 323. AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 324. AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 325. AFRICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 326. AFRICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 327. AFRICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 328. AFRICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 329. AFRICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 330. AFRICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 331. AFRICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. AFRICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 335. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 336. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 337. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 338. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 339. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 340. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 341. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 342. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 343. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 344. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 345. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 346. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 347. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 348. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 349. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 350. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE,